The U.S. Food and Drug Administration (FDA) will host a webinar on protective barrier enclosure emergency use authorizations (EUAs), as part of the series on Respirators and Other Personal Protective Equipment (PPE) for Health Care Personnel Use during the COVID-19 Pandemic.
During this webinar, the FDA will share information about protective barrier enclosures and representatives from the FDA and the Occupational Safety and Health Administration (OSHA) will be available to answer your questions.
Personal protective equipment (PPE) refers to protective clothing, helmets, gloves, face shields, goggles, surgical masks, respirators or other equipment designed to protect the wearer from injury or the spread of microorganisms.
A protective barrier enclosure is a transparent device designed to cover a patient’s head and upper body and incorporates one or more ports through which the health care provider’s (HCP) hands are passed to perform medical procedures, and provides an extra layer of barrier protection in addition to personal protective equipment (PPE). A protective barrier enclosure with negative pressure is a barrier device with negative pressure which partially or fully covers a patient to prevent HCP exposure to pathogenic biological airborne particulates. These barrier devices include ports for medical care and/or procedures.
The FDA has held webinars on topics including respirators, surgical masks, gowns, and other apparel used by health care personnel during the COVID-19 pandemic. See previous webinars from this series.